Cognitive meets computer in a scientific merger that’s reshaping how cognitive science researchers approach Alzheimer’s disease. Thanks to Artificial Intelligence (AI) developed by IBM and Pfizer, researchers may be able to detect crucial warning signs of the neurological disorder — earlier.  To say the realm…